Skip to main content
. 2014 Jan 30;25(4):850–863. doi: 10.1681/ASN.2013030251

Figure 2.

Figure 2.

Box plot of the number of NS relapses over 1 year of follow-up after rituximab administration, and during the year before rituximab administration in the study group as a whole (overall), and in different age (children versus adults) and diagnosis (MCD/MesGN versus FSGS) subgroups considered separately.